Mike Waring
Newcastle University

Biography
Mike Waring is Chair of Medicinal ÀË»¨Ö±²¥ at Newcastle University and Head of ÀË»¨Ö±²¥ for the Cancer Research UK Newcastle Drug Discovery Unit. He was previously Principal Scientist in Medicinal ÀË»¨Ö±²¥ at AstraZeneca. He has worked mainly in the areas of diabetes and oncology and his work has contributed to the discovery of 14 drug candidates, including the marketed EGFR inhibitor osimertinib (Tagrissoâ„¢).
He has made significant contributions to the field in many areas, perhaps most notably property-based optimisation, covalent inhibition, novel binding modes and new methods of hit generation. He is a 2018 American Chemical Society Hero of ÀË»¨Ö±²¥ and recipient of the 2017 RSC Malcolm Campbell Medal. He is an elected fellow of the ÀË»¨Ö±²¥.
RSC affiliations
Editor-in-Chief, RSC Medicinal ÀË»¨Ö±²¥
Contact Mike Waring
UK